Re-evaluating the Duration in Children of TB Treatment

NCT07656012 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

230

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Rifampicin
DRUG: Isoniazid
DRUG: Pyrazinamide
DRUG: Ethambutol
DRUG: Rifampicin

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]